Vanda Pharmaceuticals (VNDA) Capital Expenditures (2009 - 2026)
Vanda Pharmaceuticals (VNDA) recorded Capital Expenditures of $190,000 in Q2 2026, down 36.5% from $299,000 a year earlier and down 14.0% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Capital Expenditures (2009 - 2026) Analysis & Trends
On a TTM basis, Vanda Pharmaceuticals' Capital Expenditures came in at $674,000 as of Jun 30, 2026, down 39.3% year-over-year; for FY2025, it came in at $998,000, up 103.7% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $490,000 in FY2024 (+27.9%), $383,000 in FY2023 (-43.6%), $679,000 in FY2022 (+23.0%) and $552,000 in FY2021 (-69.2%).
- Quarterly Capital Expenditures has ranged from -$10,000 in Q3 2021 to $436,000 in Q1 2025 over the past five years.
- On a year-over-year basis, Capital Expenditures has declined for three consecutive quarters, with growth averaging 84.9% over the last seven quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 570.8% in Q3 2024, against a decline of 86.3% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $221,000 (Q1 2026), $102,000 (Q4 2025) and $161,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn | 311,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 311,000.00 |
| Jun 30, 2026 | 190,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 299,000.00 |
| Mar 31, 2025 | 436,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 108,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 253,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 263,000.00 |
| Sep 30, 2022 | 148,000.00 |
| Jun 30, 2022 | 193,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 134,000.00 |
API Access
Vanda Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();